人呼吸道合胞病毒A型RT-LAMP荧光探针快速检测方法的建立及临床验证

Development and clinical validation of rapid RT-LAMP fluorescent probe-based detection method for human respiratory syncytial virus A

  • 摘要: 目的 建立一种基于逆转录环介导等温扩增(RT-LAMP)与荧光探针技术相结合的人呼吸道合胞病毒A型(HRSV-A)快速检测方法,为现场快速筛查场景提供技术支持。方法 以HRSV-A的M基因保守区为靶标,设计特异性引物及探针,优化建立25 μl反应体系,于64 ℃恒温反应30 min,实时荧光监测核酸扩增过程。采用微滴数字聚合酶链反应(PCR)对重组质粒进行绝对定量以评估分析灵敏度,并使用11种常见呼吸道病原体标准品验证其特异性。进一步采用商品化HRSV分型试剂盒(RT-PCR法)与本研究建立的RT-LAMP荧光探针法对160例临床样本进行平行检测,综合评价其诊断效能。结果 本研究建立的RT-LAMP荧光探针法对HRSV-A的检测限为500 copies/ml;特异性结果显示,仅对HRSV-A产生特异性扩增,与HRSV-B及其他呼吸道病原体均无交叉反应。临床样本验证显示,与商品化HRSV分型试剂盒相比,总符合率为100.00%,灵敏度和特异性均为100.00%,Kappa值为1.000(95%CI:1.000~1.000),检测全程约22.53 min。结论 本研究成功建立了一种基于RT-LAMP荧光探针技术的HRSV-A快速检测方法。该方法具有快速、灵敏、特异等特点,可在30 min内完成检测,适用于发热门诊、儿科门诊等现场快速筛查场景。

     

    Abstract: OBJECTIVE To establish a rapid detection method for human respiratory syncytial virus A (HRSV-A) based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) combined with fluorescent probe technology, thereby providing technical support for on-site rapid screening. METHODSSpecific primers and probes were designed targeting the conserved region of the M gene of HRSV-A. A 25 μl reaction system was established and optimized, and then incubated at a constant temperature of 64 ℃ for 30 minutes, while the nucleic acid amplification process was monitored in real time by fluorescence. The analytical sensitivity was evaluated by absolute quantification of recombinant plasmids through droplet digital polymerase chain reaction (PCR), and the specificity was verified through standards of 11 common respiratory pathogens. Furthermore, a commercial HRSV typing kit (RT-PCR method) and the RT-LAMP fluorescent probe method established in this study were adopted for parallel detection of 160 clinical samples to comprehensively evaluate their diagnostic performance. RESULTSThe detection limit of the RT-LAMP fluorescent probe method established in this study for HRSV-A was 500 copies/ml. The specificity results showed that it only produced specific amplification for HRSV-A, with no cross-reactivity with HRSV-B or other respiratory pathogens. Clinical sample validation demonstrated a total concordance rate of 100.00%, with both sensitivity and specificity at 100.00%, and a Kappa value of 1.000 (95% CI: 1.000-1.000) compared to the commercial HRSV typing kit. The total detection time was approximately 22.53 minutes. CONCLUSIONS This study successfully developed a rapid detection method for HRSV-A based on RT-LAMP fluorescent probe technology. This method is rapid, sensitive, and specific, capable of completing detection within 30 minutes, and is suitable for various scenarios of on-site rapid screening, including fever clinics and pediatric outpatient departments.

     

/

返回文章
返回